Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Haemonetics Corporation (HAE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Haemonetics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
91.53 +0.54    +0.59%
04:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
92.87
+1.34
+1.46%
7:19:31 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 478,775
  • Bid/Ask: 89.69 / 92.98
  • Day's Range: 90.48 - 92.33
Haemonetics 91.53 +0.54 +0.59%

Haemonetics Corporation Company Profile

 
Get an in-depth profile of Haemonetics Corporation, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

3034

Equity Type

ORD

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system, and Donor360. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital’s blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient’s overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot including collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Contact Information

Address 125 Summer Street
Boston, 02110
United States
Phone 781 848 7100
Fax -

Top Executives

Name Age Since Title
Christopher A. Simon 57 2016 CEO, President & Director
Ellen M. Zane 69 2018 Independent Chairman
Robert E. Abernathy 67 2017 Independent Director
Mark W. Kroll 69 2006 Independent Director
Charles J. Dockendorff 67 2014 Independent Director
Michael J. Coyle 61 2020 Independent Director
Claire Pomeroy 68 2019 Independent Director
Martin Schreiber - - Member of Scientific Advisory Council
Jonathan Waters - - Member of Scientific Advisory Council
Marlene S. Williams - - Member of Scientific Advisory Council
Lloyd Emerson Johnson 69 2021 Independent Director
Michael F. Murphy - - Member of Scientific Advisory Council
Melissa Cushing - - Member of Scientific Advisory Council
James Grotta - - Member of Scientific Advisory Council
Donat R. Spahn - - Member of Scientific Advisory Council
Kai Zacharowski - - Member of Scientific Advisory Council
Diane M. Bryant 61 2023 Director
Edward L. Snyder 77 - Member of Scientific Advisory Council
Bryan A. Cotton - - Member of Scientific Advisory Council
Paul N. Ness - - Member of Scientific Advisory Council
Marco Ranucci - - Member of Scientific Advisory Council
Steven Frank - - Member of Scientific Advisory Council
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HAE Comments

Write your thoughts about Haemonetics Corporation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email